Although our research is the first to indicate that the therapy-induced chemoresistance of breast cancer is regulated by PTPRZ1, the mechanism behind the decreases in the other splicing variants and deglycosylated isoforms that occur during chemotherapy need further exploration. The gene discussed is PTPRZ1; the disease is breast cancer.